Updated Health Professional Product Information (PI)

Product Name Date Updated Download PDF
PI Yervoy
ipilimumab
date_range 30 Apr 2025
PI Opdualag
nivolumab with relatlimab
date_range 30 Apr 2025
PI Opdivo
nivolumab
date_range 30 Apr 2025
PI Scemblix
asciminib hydrochloride
date_range 30 Apr 2025
PI Imfinzi
durvalumab
date_range 29 Apr 2025
PI Contrave 8/90
naltrexone hydrochloride with bupropion hydrochloride
date_range 28 Apr 2025
PI Tevimbra
tislelizumab
date_range 28 Apr 2025
PI Jemperli
dostarlimab
date_range 28 Apr 2025
PI Creon
pancreatic extract
date_range 24 Apr 2025
PI Abilify Maintena Therapeutic Kit
aripiprazole
date_range 24 Apr 2025
PI Tagrisso
osimertinib mesilate
date_range 23 Apr 2025
PI Dexamethasone Viatris
dexamethasone sodium phosphate
date_range 23 Apr 2025
PI Vyalev
foslevodopa and foscarbidopa
date_range 23 Apr 2025
PI Epipen
adrenaline (epinephrine)
date_range 23 Apr 2025
PI Epipen Jr
adrenaline (epinephrine)
date_range 23 Apr 2025
PI Adrenaline Viatris
adrenaline (epinephrine)
date_range 23 Apr 2025
PI Adrenaline Jr Viatris
adrenaline (epinephrine)
date_range 23 Apr 2025
PI Beyfortus
nirsevimab
date_range 23 Apr 2025
PI Mayzent
siponimod
date_range 22 Apr 2025
PI Ultomiris 100 mg/ml
ravulizumab
date_range 22 Apr 2025

Sponsored and funded by

Medadvisor logo

MedAdvisor International Pty Limited
ABN 40 161 366 589
Suite 2, Level 7, 500 Bourke Street
Melbourne VIC 3000
Australia

Affiliates